NASDAQ
Neuropace, Inc. (NPCE)
♥ 506 Thanks from members
NeuroPace (NPCE) demonstrates accelerating RNS System revenue growth and narrowing losses, though its premium valuation is tempered by a recent FDA regulatory setback for its IGE label expansion and lingering liquidity risks.